Protocol No
BEONE-BG-75098-101
Staff Member
Deepak Kilari
Phase
I
Summary
The purpose of this study is to test if the study drug BG-75098 is safe and tolerable and if it works in treating patients with cancer when it is given on its own or in combination with BGB-43395 and fulvestrant.
Objective
A Phase 1 study of BG-75098 alone and in combination with BGB-43395 and/or Fulvestrant in Patients with Advanced Solid Tumors.
Status
OPEN TO ACCRUAL
Categories
Cancer,
Early Phase/Multiple Disease Site Cancers,
Other Respiratory,
Other Skin,
Pancreas/Liver,
Prostate,
Other Gynecologic,
Colorectal,
Skin Cancers,
Gynecologic Cancers,
Bladder,
Lung,
Other Gastrointestinal,
Esophagus,
Breast Cancers,
Esophagus,
Gastrointestinal Cancers,
Prostate and Urologic Cancers,
Sarcoma,
Lip, Oral Cavity and Pharynx,
Thoracic Cancers,
Head and Neck Cancers
ClinicalTrials.gov